Computer-aided detection developer Rcadia Medical Imaging of Haifa, Israel, has received the European CE Mark for its COR Analyzer, its proprietary software that helps identify patients with significant coronary artery disease by automatic analysis of coronary CT angiography (CTA) studies.
COR Analyzer is designed to process patient images from coronary CTA studies generated by all four manufacturers of 64-slice (and above) CT systems and produce results in real-time that determine whether significant lesions are present in major coronary arteries.
The software has already been cleared by the U.S. Food and Drug Administration.
Related Reading
Rcadia lands investment, December 16, 2008
Rcadia debuts COR Analyzer for coronary CTA, December 3, 2008
Rcadia adds distributor, November 20, 2007
Rcadia establishes U.S. beta site, October 30, 2007
Rcadia nets FDA nod, September 26, 2007
Copyright © 2010 AuntMinnie.com
![Axial images from unenhanced calcium score cardiac CT (left) and curved planar reformation images from CT angiography (right) show that higher long-term exposure to air pollution is associated with greater coronary artery calcium and more obstructive coronary artery disease (CAD). Top row: Images in a 68-year-old male patient with higher 10-year mean ambient air pollution exposure (7.9 μg/m3 for particulate matter measuring ≤2.5 μm in diameter [PM2.5] and 17.4 parts per billion [ppb] for NO2) with extensive CAD (coronary artery calcium score [CACS] >1,000 and obstructive CAD [≥70% diameter stenosis]). Bottom row: Images in a 57-year-old female patient with lower 10-year mean ambient air pollution exposure (6.3 μg/m3 for PM2.5 and 4.6 ppb for NO2) with no CAD (CACS = 0 and no obstructive stenosis).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/hanneman.r6SMLzkezo.png?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
